These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8764117)

  • 1. GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells.
    Friedman AD
    Cancer Res; 1996 Jul; 56(14):3250-6. PubMed ID: 8764117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells.
    Cao W; Britos-Bray M; Claxton DF; Kelley CA; Speck NA; Liu PP; Friedman AD
    Oncogene; 1997 Sep; 15(11):1315-27. PubMed ID: 9315100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B; Dubrez L; Allouche M; Solary E
    Cancer Res; 1997 Feb; 57(4):686-95. PubMed ID: 9044846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts.
    Wang X; Scott E; Sawyers CL; Friedman AD
    Blood; 1999 Jul; 94(2):560-71. PubMed ID: 10397723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
    Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW
    Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal cytoplasmic region of the granulocyte colony-stimulating factor receptor mediates apoptosis in maturation-incompetent murine myeloid cells.
    Dong F; Pouwels K; Hoefsloot LH; Rozemuller H; Löwenberg B; Touw IP
    Exp Hematol; 1996 Feb; 24(2):214-20. PubMed ID: 8641344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding.
    Cleaves R; Wang QF; Friedman AD
    Oncogene; 2004 Jan; 23(3):716-25. PubMed ID: 14737106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cells.
    Britos-Bray M; Sacchi N; Friedman AD
    Leukemia; 1996 Jun; 10(6):984-90. PubMed ID: 8667656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response.
    Fawcett TW; Martindale JL; Guyton KZ; Hai T; Holbrook NJ
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):135-41. PubMed ID: 10085237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene.
    van Dijk TB; Baltus B; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
    J Immunol; 1999 Sep; 163(5):2674-80. PubMed ID: 10453008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G).
    Mavilio F; Kreider BL; Valtieri M; Naso G; Shirsat N; Venturelli D; Reddy EP; Rovera G
    Oncogene; 1989 Mar; 4(3):301-8. PubMed ID: 2468124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter.
    Clarke SL; Robinson CE; Gimble JM
    Biochem Biophys Res Commun; 1997 Nov; 240(1):99-103. PubMed ID: 9367890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
    Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
    Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.
    Gómez-Santos C; Barrachina M; Giménez-Xavier P; Dalfó E; Ferrer I; Ambrosio S
    Brain Res Bull; 2005 Feb; 65(1):87-95. PubMed ID: 15680548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of GADD153 (growth arrest- and DNA damage-inducible gene 153) in vascular smooth muscle cell apoptosis.
    Igase M; Okura T; Nakamura M; Takata Y; Kitami Y; Hiwada K
    Clin Sci (Lond); 2001 Mar; 100(3):275-81. PubMed ID: 11222113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHOP activation by photodynamic therapy increases treatment induced photosensitization.
    Wong S; Luna M; Ferrario A; Gomer CJ
    Lasers Surg Med; 2004; 35(5):336-41. PubMed ID: 15611953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
    Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
    Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
    Kuroda M; Ishida T; Takanashi M; Satoh M; Machinami R; Watanabe T
    Am J Pathol; 1997 Sep; 151(3):735-44. PubMed ID: 9284822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
    Crozat A; Aman P; Mandahl N; Ron D
    Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.